Compare XRAY & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | XRAY | TMDX |
|---|---|---|
| Founded | 1899 | 1998 |
| Country | United States | United States |
| Employees | N/A | 898 |
| Industry | Medical/Dental Instruments | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.6B | 2.2B |
| IPO Year | 2008 | 2019 |
| Metric | XRAY | TMDX |
|---|---|---|
| Price | $9.73 | $66.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $14.58 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 4.7M | 1.6M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 5.58% | N/A |
| EPS Growth | 33.04 | ★ 382.18 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $605,494,000.00 |
| Revenue This Year | N/A | $24.25 |
| Revenue Next Year | $2.06 | $18.75 |
| P/E Ratio | ★ N/A | $342.80 |
| Revenue Growth | N/A | ★ 37.13 |
| 52 Week Low | $9.85 | $60.11 |
| 52 Week High | $17.09 | $156.00 |
| Indicator | XRAY | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 24.31 | 27.58 |
| Support Level | N/A | N/A |
| Resistance Level | $13.06 | $131.86 |
| Average True Range (ATR) | 0.48 | 4.65 |
| MACD | -0.16 | -1.30 |
| Stochastic Oscillator | 12.55 | 15.09 |
Dentsply Sirona is one of the world's largest manufacturers of dental equipment and supplies. It is a result of a merger of equals in 2016 between Dentsply International (dental consumables and lab products) and Sirona Dental Systems (technologically advanced dental equipment). The firm's wide portfolio consists of dental consumables, lab products, CAD/CAM and imaging technology, medical devices, and specialty products in orthodontics, endodontics, and implantation. It distributes two-thirds of its dental consumables, technology, and equipment through third-party distributors. The remaining portfolio is sold to labs and offices through the firm's salesforce or directly to consumers (such as the Byte clear aligner).
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.